Alpha-Lipoic Acid: Neuropathy Evidence, Limits
Alpha-lipoic acid: a meta-analysis of 10 RCTs found it reduced symptoms in diabetic neuropathy, but no trial supports a longevity claim.
Researched from published studies and manufacturer specifications, checked .
We have not tested products ourselves. How we research
Quick verdict
Alpha-lipoic acid has evidence in one condition: a meta-analysis of 10 RCTs (1,242 patients) found oral ALA improved symptom scores in diabetic polyneuropathy. Nerve conduction and several other measures did not improve. No trial we found supports a longevity claim. It can affect blood sugar, so ask your doctor.
Talk to your doctor first. This is general information, not medical advice. Supplements and devices can interact with medicines and health conditions. We quote study protocols for context and do not recommend doses.
The short answer: alpha-lipoic acid (ALA) has evidence in one condition. A 2023 meta-analysis of 10 randomised trials (1,242 patients) found oral ALA improved total symptom score, neurological disability score and global satisfaction in diabetic polyneuropathy, but not pain scores, vibration perception or nerve conduction. No trial we found supports a longevity claim. ALA can lower blood sugar, so talk to your doctor, especially if you take diabetes medicines.
What the evidence shows
Grade: Moderate for diabetic neuropathy symptoms; not shown for longevity.
| Question | Evidence | Limit |
|---|---|---|
| Diabetic polyneuropathy | 10 RCTs, 1,242 patients: better total symptom score (dose-related trend), disability score and global satisfaction; no favourable result for VAS, vibration perception threshold, NIS-LL or nerve conduction | Patients with diabetic neuropathy; symptom scores are subjective |
| Longevity in healthy people | None found | No claim made |
Related: berberine and metformin for other glucose-related topics, the graded supplement ladder and glucose tracking. Products (Amazon links, we may earn a commission; contents not verified): Thorne ALA, Jarrow R-ALA.
Method note
Read for this page: Oral alpha-lipoic acid in diabetic polyneuropathy, meta-analysis and systematic review (Nutrients 2023). Checked 29 Sept 2026. Abstract only. We did not test any product. General information, not medical advice: this page gives no dose.
Common questions
What is alpha-lipoic acid good for?
The best evidence is symptom relief in diabetic polyneuropathy: a 2023 meta-analysis of 10 RCTs (1,242 patients) found favourable results for total symptom score, neurological disability score and global satisfaction, with a dose-related trend, but not for pain VAS, vibration threshold, NIS-LL or nerve conduction.
Does alpha-lipoic acid help longevity?
No trial we found shows that. This page makes no longevity claim.
Sources
Update log
- Sourcing pass: removed unsourced antioxidant, mitochondrial and longevity claims, dose advice and brand claims; kept the diabetic neuropathy meta-analysis, which is the one indication we could verify.
Data and comparisons
- Berberine evidence record
Often called "natural metformin"
- NMN evidence record
A direct NAD+ precursor that restores declining NAD+ levels with age
- Resveratrol evidence record
A polyphenol that activates sirtuins (SIRT1)
Related reading
Collagen Supplements: Skin Evidence and Limits
Collagen supplements: a review of 10 publications found skin benefits; evidence for joints, bones or longevity is not shown here.
Resveratrol and Pterostilbene: Trial Evidence
Resveratrol from human data: no link to mortality in older adults, better glucose control only in people with diabetes, and no trial for longevity.
Creatine for Longevity: Evidence, Forms, Cost
Creatine monohydrate from meta-analyses: muscle, memory and bone in older adults, kidney and hair concerns, and monthly cost at a trial dose.